Cartesian Therapeutics In... (RNAC)
NASDAQ: RNAC
· Real-Time Price · USD
9.46
-0.61 (-6.06%)
At close: Sep 25, 2025, 3:59 PM
9.57
1.16%
After-hours: Sep 25, 2025, 04:19 PM EDT
Cartesian Therapeutics Revenue
Cartesian Therapeutics reported an annual revenue of $38.91M, reflecting a 49.64% growth. For the quarter ending June 30, 2025, Cartesian Therapeutics generated $298K in revenue.
Revenue (ttm)
38.91M
Revenue Growth
49.64%
Price / Sales Ratio
11.92
Revenue / Employee
589.59K
Employees
66
Market Cap
245.98M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 38.91M | +49.64% |
| Dec 31, 2023 | 26M | -76.53% |
| Dec 31, 2022 | 110.78M | +30.21% |
| Dec 31, 2021 | 85.08M | +412.60% |
| Dec 31, 2020 | 16.6M | +148.57% |
| Dec 31, 2019 | 6.68M | +639.42% |
| Dec 31, 2018 | 903K | +336.23% |
| Dec 31, 2017 | 207K | -97.44% |
| Dec 31, 2016 | 8.08M | +34.47% |
| Dec 31, 2015 | 6.01M | +97.73% |
| Dec 31, 2014 | 3.04M | n/a |